Tuatara Capital
VC Fund
New York, United States
Tuatara Capital is a VC fund in New York focused on Cannabis and Biotechnology. Tuatara Capital they provide strategic, financial, and operational support in building industry and businesses to help cannabis industry.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 82%
- Fund size:
- $9.4M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Tuatara Capital invests in
Stages Tuatara Capital invests in
Countries Tuatara Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Series A
- $3M–$50M
- Series B
- $6.5M–$12M
- Post-IPO Equity
- $1.3M–$13M
Investment Focus
Industry
- Cannabis 6 (55%)
- Biotechnology 4 (36%)
- Health Care 3 (27%)
- Life Science 2 (18%)
- Medical Device 2 (18%)
Stage
- Series A 5 (45%)
- Series B 2 (18%)
- Post-IPO Equity 2 (18%)
- Convertible Note 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- United States 8 (73%)
- Canada 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sergey Sherman
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Al Foreman
Co-Founder, Partner & Chief Investment Officer
|
Co-Founder, Partner & Chief Investment Officer | Total investments: 0 | Find email | |
Al Foreman
Co-Founder, Partner & Chief Investment Officer
|
Co-Founder, Partner & Chief Investment Officer | Total investments: 3 | Find email | |
|
Marc Riiska
Co-Founder, Managing Partner & Chief Operating Officer
|
Co-Founder, Managing Partner & Chief Operating Officer | Total investments: 0 | Find email | |
|
Mark Zittman
Co-Founder, Partner & Chairman
|
Co-Founder, Partner & Chairman | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Springbig provides loyalty, digital communications, and CRM technology solutions to retailers in the cannabis industry. It was founded in 2012 and is headquartered in Boca Raton, Florida. After years of experience in big-box retail, their founders saw tremendous opportunity in the underserved cannabis industry and decided to bring advanced loyaltyprograms, an essential marketing tool in such a competitive industry, to cannabis dispensaries and brands. | $13M / Post-IPO Equity / Jun 15, 2022 | ||
| Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. | $20M / Venture - Series Unknown / Sep 03, 2021 | ||
| Willow Biosciences is a multidisciplinary team of discovery biologists, biochemists, and geneticists. It specializes in the fields of biotechnology and healthcare. | $1.3M / Post-IPO Equity / Nov 03, 2020 | ||
| Demetrix manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. It enables refactoring biotechnology microbial hosts for gene synthesis. The company engineers strain to produce co-evolved and bio-inspired medicines and nutraceuticals.The company was foundedin 2015 and is headquartered in Emeryville, California. | $50M / Series A / Jul 11, 2019 | ||
| Green Flower is an e-learning company that specializes in providing online cannabis education. Its technology provides students the knowledge and skills they needed to enter into or advance in the cannabis industry. The company was founded in 2014 and headquartered in Ventura, California. | $20M / Series A / Jun 19, 2019 | ||
| Enlighten offers targeted POS advertisement through its streaming channel and interactive signage in order to inform and educate customers with professionally curated entertainment and educational content, allowing cannabis companies to grow their brand and build relationships with their customers through a variety of solutions. | $6.5M / Series B / Jun 12, 2019 | ||
| Enlighten offers targeted POS advertisement through its streaming channel and interactive signage in order to inform and educate customers with professionally curated entertainment and educational content, allowing cannabis companies to grow their brand and build relationships with their customers through a variety of solutions. | $3M / Series A / Feb 01, 2018 | ||
| Willie Nelson has never made any bones about it. The cannabis culture is a way of life for him. And he has always operated under a simple philosophy: my stash is your stash. | $12M / Convertible Note / Jan 31, 2018 | ||
| Green Dot Labs committed to using the safest, most responsible extraction methods possible in their state-of-the-art laboratory. They respect the environment, their employees, and their consumers and they have gone to great lengths to ensure the wellbeing of all. | $3.3M / Series A / Sep 13, 2017 | ||
| Teewinot Life Sciences is a global biopharmaceutical company focused on the biosynthetic production of pure pharmaceutical grade cannabinoids. Teewinot has developed patent protected processes for production of pure cannabinoids by means of biocatalysis and synthetic biology. Teewinot has also developed patent protected cannabinoid formulationtechnology all with the goal of improving human therapies. Headquartered in Tampa, Florida, Teewinot manufactures and licenses technology to make cost-effective and pharmaceutically pure cannabinoids. We are an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid-based medicines. | $12.3M / Series B / May 01, 2017 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tuatara Capital invest in?
Tuatara Capital invests primarily in Cannabis, Biotechnology and Health Care startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Tuatara Capital invest in?
Tuatara Capital typically joins rounds of $3M–$50M at Series A, $6.5M–$12M at Series B and $1.3M–$13M at Post-IPO Equity. These are whole funding-round sizes, not Tuatara Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Tuatara Capital took part in.
How do I contact Tuatara Capital?
Public channels for Tuatara Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tuatara Capital?
The team at Tuatara Capital includes Sergey Sherman (Managing Director), Al Foreman (Co-Founder, Partner & Chief Investment Officer) and Al Foreman (Co-Founder, Partner & Chief Investment Officer), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
